COVID-19 Vaccines
Vaccine Eligibility
First and second doses
These individuals are currently eligible for first or second doses of a COVID-19 vaccine.
5 to 11 year olds
Dose | Eligible population | How to access vaccine |
---|---|---|
1st or 2nd dose (2nd dose 8 weeks after 1st dose) |
Children must be five years old or older at the time of vaccination. Eligibility is based on date of birth and will be confirmed at the time of vaccination. |
|
12 years of age or older
Dose | Eligible population | How to access vaccine |
---|---|---|
1st or 2nd dose (8 weeks after 1st dose) |
Individuals who are age 12 and older. Eligibility is based on date of birth and will be confirmed at the time of the appointment. |
|
Third or booster doses
These individuals are currently eligible for third or booster doses of a COVID-19 vaccine.
Individuals age 12 to 17
Dose | Eligible population | How to access vaccine |
---|---|---|
Booster dose |
Individuals age 12 to 17. Eligibility is based on date of birth and will be confirmed at the time of the appointment. Plan to get your vaccine after your 12th birthday. |
|
18 years of age or older
Dose | Eligible population | How to access vaccine |
---|---|---|
3 months (84 days) or more after 2nd dose |
Individuals age 18 and older Eligibility is based on date of birth and will be confirmed at the time of the appointment. Plan to get your vaccine after your 18th birthday. |
|
Pregnant individuals
Dose | Eligible population | How to access vaccine |
---|---|---|
Booster dose 3 months (84 days) or more after 2nd dose |
Pregnant individuals |
|
Individuals who received 2 doses of AstraZeneca
Dose | Eligible population | How to access vaccine |
---|---|---|
Booster dose, 3 months (84 days) or more after 2nd dose |
Individuals who received a complete series of a viral vector vaccine (two doses of AstraZeneca vaccine or one dose of J & J/Janssen vaccine) |
Individuals can receive an mRNA vaccine (Pfizer, where supply is available, or Moderna) for a booster dose. |
Immunocompromised individuals
Dose | Eligible population | How to access vaccine |
---|---|---|
3rd dose, 8 weeks (56 days) or more after 2nd dose |
Immunocompromised populations age 5+:
|
Eligible individuals can show a current prescription receipt from a pharmacy or the medication bottle or packaging that includes the date of prescription, their first and last name, and the address and phone number of the pharmacy to receive their third dose of COVID-19 vaccine. See list of eligible immunosuppressive medications. Clinical staff will verify eligibility at vaccine clinics. If eligible individuals do not have a prescription, or the drug is not listed by Ministry, a referral form from the treating health care provider (doctor, nurse practitioner, specialist, hospital specialty program) must be provided at the clinic to receive a third dose of a COVID-19 vaccine. Timing of the third dose should be decided with the treating provider in order to optimize immune response and minimize delays in management of underlying conditions. |
Seniors in congregate living facilities
Dose | Eligible population | How to access vaccine |
---|---|---|
3rd dose, 3 months (84 days) or more after 2nd dose |
Seniors living in congregate settings including:
|
Registration through facility |
Fourth doses
The following individuals are currently eligible for fourth doses of a COVID-19 vaccine.
Adults (Age 60+)
Dose | Eligible population | How to access vaccine |
---|---|---|
4th dose |
Individuals age 60 and older. |
|
First Nation, Inuit and Métis individuals and their non-Indigenous household members (Age 18+)
Dose | Eligible population | How to access vaccine |
---|---|---|
4th dose |
First Nation, Inuit and Metis individuals and their non-Indigenous household members who are age 18 and older. Eligibility is based on date of birth and will be confirmed at the time of the appointment. |
|
Seniors in congregate living facilities
Dose | Eligible population | How to access vaccine |
---|---|---|
4th dose, 3 months (84 days) or more after 3rd dose |
Residents of high-risk congregate settings including:
Older adults living in other congregate settings providing assisted-living and health services. |
Registration through facility |
Immuno-compromised individuals
Individuals eligible for 3-dose primary series of the COVID-19 vaccine are eligible for a fourth dose.
Dose | Eligible population | How to access vaccine |
---|---|---|
4th dose Age 18+: 3 months (84 days) or more after 3rd dose Age 12-17: 6 months (168 days) or more after 3rd dose |
Immunocompromised populations age 12+:
|
Eligible individuals can show a current prescription receipt from a pharmacy or the medication bottle or packaging that includes the date of prescription, their first and last name, and the address and phone number of the pharmacy to receive their fourth dose of COVID-19 vaccine. See list of eligible immunosuppressive medications. Clinical staff will verify eligibility at vaccine clinics. If eligible individuals do not have a prescription, or the drug is not listed by Ministry, a referral form from the treating health care provider (doctor, nurse practitioner, specialist, hospital specialty program) must be provided at the clinic to receive a fourth dose of a COVID-19 vaccine. Timing of the fourth dose should be decided with the treating provider in order to optimize immune response and minimize delays in management of underlying conditions. |
Fifth doses
The following individuals are currently eligible for fifth doses of a COVID-19 vaccine.
Immuno-compromised individuals
Individuals who received a 3-dose primary series of the COVID-19 vaccine are eligible for a second booster (5th dose) only if they fall into one of the groups below.
Dose | Eligible population | How to access vaccine |
---|---|---|
5th dose 5 months (140 days) or more after 4th dose |
Immunocompromised individuals who received a 3-dose primary series and must also fit into one of the following groups:
Immunocompromised individuals:
|
Eligible individuals can show a current prescription receipt from a pharmacy or the medication bottle or packaging that includes the date of prescription, their first and last name, and the address and phone number of the pharmacy to receive their fourth dose of COVID-19 vaccine. See list of eligible immunosuppressive medications. Clinical staff will verify eligibility at vaccine clinics. If eligible individuals do not have a prescription, or the drug is not listed by Ministry, a referral form from the treating health care provider (doctor, nurse practitioner, specialist, hospital specialty program) must be provided at the clinic to receive a fourth dose of a COVID-19 vaccine. Timing of the fifth dose should be decided with the treating provider in order to optimize immune response and minimize delays in management of underlying conditions. |
After vaccination
It is vital that everyone, even those who have been vaccinated, continue practicing public health measures including:
- staying home if you have any COVID-19 symptoms
- getting tested for COVID-19 if you have symptoms or have been in close contact with a confirmed positive case of COVID-19, if eligible.
- keeping your distance from others
- wearing a mask or face covering
- washing hands frequently
Misinformation
Resources to help you decide if the information you’re getting is fact:
Related links
If you have general questions about the COVID-19 vaccine:
- Call the COVID-19 Hotline at 905-974-9848, option 7
- Email [email protected]
- Date modified: